115 - Post-licensure Safety Study of New-onset Immune-mediated Diseases, Herpes Zoster, and Anaphylaxis in Adult Recipients of HepB-CPG Vaccine Versus HepB-alum Vaccine

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Virtual

Presenting Author(s)

Bradley Ackerson, MD (he/him/his)

Co-Investigator
Kaiser Permanente Southern California
Pasadena, California, United States

LS

Lina S. Sy, MPH

Ms.
Kaiser Permanente Southern California
Pasadena, California, United States
JS

Jeff Slezak, MS

Research Scientist Biostatistician
Kaiser Permanente Southern California
Pasadena, California, United States
LQ

Lei Qian, PhD

Research Scientist I
Kaiser Permanente Southern California
Pasadena, California, United States
KR

Kristi Reynolds, PhD

Research Scientist
Kaiser Permanente Southern California
Pasadena, California, United States
RH

Runxin Huang, MS

Analyst
Kaiser Permanente Southern California
Pasadena, California, United States
ZS

Zendi Solano, BS

Research Associate IV
Kaiser Permanente Southern California
Pasadena, California, United States
William Towner, MD

Division Director, Clinical Trial Research
Kaiser Permanente Southern California
Pasadena, California, United States
SQ

Sijia Qiu, MS

Kaiser Permanente Southern California
Pasadena, California, United States
SS

Sarah Simmons, MPH

Kaiser Permanente Southern California
Pasadena, California, United States
SJ

Steven Jacobsen, MD

Marshfield Clinic Research Institute
Iowa City, Iowa, United States
KB

Katia J. Bruxvoort, PhD, MPH

University of Alabama at Birmingham
Birmingham, Alabama, United States